Literature DB >> 11979269

Prospects for the worldwide control of colorectal cancer through screening.

Paul Rozen, Sidney J Winawer, Jerome D Waye.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11979269     DOI： 10.1067/mge.2002.123612

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  7 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

2.  Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer.

Authors:  S Vitale; B Cambien; B F Karimdjee; R Barthel; P Staccini; C Luci; V Breittmayer; F Anjuère; A Schmid-Alliana; H Schmid-Antomarchi
Journal:  Gut       Date:  2006-07-26       Impact factor: 23.059

3.  Changes in risk perceptions in relation to self-reported colorectal cancer screening among first-degree relatives of colorectal cancer cases enrolled in a randomized trial.

Authors:  Beth A Glenn; Alison K Herrmann; Catherine M Crespi; Cynthia M Mojica; L Cindy Chang; Annette E Maxwell; Roshan Bastani
Journal:  Health Psychol       Date:  2011-07       Impact factor: 4.267

Review 4.  The history of colorectal cancer screening: a personal perspective.

Authors:  Sidney J Winawer
Journal:  Dig Dis Sci       Date:  2015-01-20       Impact factor: 3.199

5.  Rates and sociodemographic correlates of cancer screening among South Asians.

Authors:  Beth A Glenn; Neetu Chawla; Zul Surani; Roshan Bastani
Journal:  J Community Health       Date:  2009-04

6.  Association between smoking and deaths due to colorectal malignant carcinoma: a national population-based case-control study in China.

Authors:  L Hou; J Jiang; B Liu; P C Nasca; Y Wu; X Zou; W Han; Y Chen; B Zhang; F Xue; H Pang; J Li
Journal:  Br J Cancer       Date:  2014-01-30       Impact factor: 7.640

Review 7.  Role of fractalkine/CX3CL1 and its receptor in the pathogenesis of inflammatory and malignant diseases with emphasis on B cell malignancies.

Authors:  Elisa Ferretti; Vito Pistoia; Anna Corcione
Journal:  Mediators Inflamm       Date:  2014-03-30       Impact factor: 4.711
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.